Table 2.

Patient data of FDG and FMISO PET (increase of FMISO uptake; increase of mean SUV of FDG uptake)

Pat.	FMISO						FDG
	SUV mean before/after Cht.		SUV max. before/after Cht.		Tu./Musc. before/after Cht.		SUV mean before/after Cht.		SUV max before/after Cht.
1	1.90	1.40	2.12	1.83	1.12	1.04	9.70	7.70	12.32	8.16
2	2.20	1.40	2.48	1.63	1.45	1.26	17.10	8.10	20.19	9.69
3	1.90	1.90	2.57	2.43	1.54	1.36	14.10	7.10	16.28	7.96
4	3.70	2.20	4.59	2.43	5.85	1.51	14.00	8.30	19.02	9.40
5	1.60	1.40	1.76	1.65	1.25	1.10	8.50	8.90	10.80	10.18
6	2.20	2.40	2.58	2.71	1.10	1.18	12.00	11.40	14.90	13.68
7a	2.60	2.00	3.02	2.28	1.86	1.75	8.60	10.60	11.85	11.99
7b	2.60	2.00	3.02	2.34	1.86	1.52	8.60	5.10	11.85	7.15
8	2.10	1.80	2.79	2.37	1.89	1.48	1.60	9.70	1.91	14.50
Mean	2.31	1.83	2.77	2.19	1.99	1.36	10.47	8.54	13.23	10.30
SD	0.20	0.12	0.27	0.13	0.49	0.08	1.50	0.63	1.80	0.86

SUV = standard uptake value; Tu./Musc. = tumour to muscle ratio; Cht. = chemotherapy